ertapenem + levofloxacin

Ertapenem + levofloxacin is a combination of two antibiotics used together, primarily in clinical or investigational settings, to treat infections caused by susceptible bacteria. Ertapenem is a carbapenem-class beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, leading to cell lysis and death. Levofloxacin is a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication, transcription, repair, and recombination. The combination has been studied for synergistic or additive effects against various Gram-negative pathogens including *Escherichia coli*, *Klebsiella pneumoniae*, and *Pseudomonas aeruginosa*. It may be considered in severe or resistant infections such as complicated urinary tract infections or pneumonia when monotherapy may not be sufficient[1][3][6]. Both drugs are approved individually but the fixed combination does not have an established brand name.